CD8A and neoplasm: In PDA, an acute response was observed between 3 and 4 days after RFA treatment where increased numbers of functional DCs, CD4+, and CD8+ T cells on day 3 after RFA treatment were reported in distant sites (16, 17); however, the immune responses were transient and with no ability to suppress tumor growth two weeks after treatment.